Global Circular RNA Drugs Market Growth 2025-2031

The global Circular RNA Drugs market size is predicted to grow from US$ 330 million in 2025 to US$ 809 million in 2031; it is expected to grow at a CAGR of 16.1% from 2025 to 2031.

Circular RNA drugs refer to therapeutics that utilize circular RNA (circRNA) molecules as the active ingredient for treating various diseases. CircRNAs are naturally occurring, non-coding RNA molecules with a covalently closed-loop structure. They have gained significant attention for their potential as therapeutic agents due to their stability, resistance to exonucleases, and ability to regulate gene expression. CircRNA-based drugs may be used in gene therapy, cancer treatment, and other applications by leveraging their ability to modulate protein expression and cellular functions.

United States market for Circular RNA Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Circular RNA Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Circular RNA Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Circular RNA Drugs players cover Orna Therapeutics, Torque Bio, Chimera Therapeutics, CirCode Bio, RiboX Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Circular RNA Drugs Industry Forecast” looks at past sales and reviews total world Circular RNA Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Circular RNA Drugs sales for 2025 through 2031. With Circular RNA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circular RNA Drugs industry.

This Insight Report provides a comprehensive analysis of the global Circular RNA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Circular RNA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circular RNA Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circular RNA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circular RNA Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Circular RNA Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Marketing
Clinical

Segmentation by Application:
Drugs
Vaccines

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Orna Therapeutics
Torque Bio
Chimera Therapeutics
CirCode Bio
RiboX Therapeutics
Sail Biomedicines
Curemed Bio

Key Questions Addressed in this Report

What is the 10-year outlook for the global Circular RNA Drugs market?

What factors are driving Circular RNA Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Circular RNA Drugs market opportunities vary by end market size?

How does Circular RNA Drugs break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.